STOCK TITAN
  1. Home
  2. News
  3. CVSI

CV Sciences Inc. - CVSI STOCK NEWS

Welcome to our dedicated news page for CV Sciences (Ticker: CVSI), a resource for investors and traders seeking the latest updates and insights on CV Sciences.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CV Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CV Sciences's position in the market.

News
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
Rhea-AI Summary
CV Sciences, Inc. reported financial results for fiscal 2023, showing a revenue of $16.0 million with a gross margin of 44.3%. Despite a slight decrease in sales, the company saw improvements in operating income and adjusted EBITDA. CV Sciences continued to expand its product offerings, launch new CBD products, receive patent approvals, and acquire Cultured FoodsTM.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.13%
Tags
earnings
-
News
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
Rhea-AI Summary
CV Sciences, Inc. launches +PlusCBD™ Pet Hip and Joint Health Chews and Pet Calming Care Chews, backed by a safety study from the National Animal Supplement Council. The chews aim to improve pets' physical and emotional well-being with CBD and other natural ingredients, addressing joint pain and anxiety. The products are available nationwide and uphold strict quality standards, offering pet owners a safe and effective alternative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
Rhea-AI Summary
CV Sciences, Inc. (CVSI) will release financial results for the year and fourth quarter ended December 31, 2023, on March 28, 2024. The Company will hold a conference call with investors on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.32%
Tags
earnings
News
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
Rhea-AI Summary
CV Sciences, Inc. (OTCQB: CVSI) has completed the acquisition of Cultured Foods, a leading manufacturer and distributor of alternative plant-based vegan foods, for a total consideration of up to $535,000. The acquisition creates opportunities for importation of specialty foods to the US and establishes a European base of operations for the sale and distribution of +PlusCBD products, contributing to the transition of CV Sciences into a more diverse global health and wellness company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
CV Sciences, Inc. (OTCQB:CVSI) announced its financial results for the quarter ended September 30, 2023, with increased revenue to $4.1 million, recognized gross margin of 45.1%, and a cash balance of $1.6 million. The company also launched new products, executed an M&A strategy, and evaluated partnership opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
Rhea-AI Summary
CV Sciences, Inc. (OTCQB:CVSI) will release financial results for the third quarter ended September 30, 2023, before the stock market opens on Tuesday, November 14, 2023. The company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day. Investors interested in participating in the live call can also dial (877) 300-8521 from the U.S. or international callers can dial (412) 317-6026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
News
CV Sciences, Inc. Launches Reserve Sleep Gummies
Rhea-AI Summary
CV Sciences launches +PlusCBD™ Reserve Collection Sleep Gummies to expand into the sleep aid market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
Rhea-AI Summary
CV Sciences, Inc. will release financial results for Q2 2023 on August 14, 2023. A conference call with the investment community will be held on the same day. The webcast of the call will be available on the Company's website. A telephone replay will also be available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
News
CV Sciences to Participate in LD Micro Invitational Conference
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Stock CVSI logo
CV Sciences Inc.

OTC:CVSI

CVSI Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

CVSI Stock Data

6.20M
163.20M
0.02%
0%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
US
San Diego

About CVSI

cv sciences: integrating science and nature, improving health and well-being at cv sciences, our mission is to make healthy people healthier. our dedication to consumer well-being underscores our values, operations, and products.